Effects of melatonin on heart health during menopause
Official title: Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial
Run by Mayo Clinic · NCT06826755 · Data updated 2026-11-12
This study is testing if taking melatonin for 12 weeks can help improve heart health in women aged 40-55 who are going through perimenopause and have high blood pressure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 55 Years |
| Sex | Women only |
| Enrollment | 70 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | May 23, 2025 |
| Main results expected | September 2027 |
| Study ends | January 2028 |
| Registry record updated | August 13, 2026 |
| Trial ID | NCT06826755 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 40-55 in the menopause transition with a diagnosis of hypertension.
✕Probably not a fit
Patients who are currently using prescription sleeping medications or hormonal contraceptives may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the impact of 12 weeks of melatonin supplementation on cardiovascular disease mechanisms in women experiencing perimenopause and hypertension. Participants will receive either melatonin or a placebo to assess changes in blood pressure and related cardiovascular markers. The study aims to determine if melatonin can provide a therapeutic benefit during this transitional phase of menopause. The trial is designed to include women aged 40-55 who meet specific criteria regarding their menstrual cycle and hypertension status.
Why it matters
Potential benefit: If successful, this study could provide a new treatment option for managing hypertension in women undergoing menopause.
How similar studies have gone: While there is limited research specifically on melatonin for cardiovascular health in menopause, similar studies on melatonin's effects on hypertension have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Age 40-55 years old * Female individuals with intact uterus and at least one ovary * Hypertension o Defined as a prior diagnosis of hypertension, use of antihypertensive agents, or office SBP/DBP ≥130/80 mmHg * On stable medical regimen (≥ 2 months) if taking other medications Exclusion Criteria * Prescription sleeping medications or melatonin supplementation * Pregnant or lactating * Use of tobacco, nicotine or vaping products * Night shift work * On prescription aspirin * Severe lactose intolerance * History of substance use disorder * History of suicidal ideation * History of clinically diagnosed anemia (within the past 5 years) or low hemoglobin levels (\<11.6 g/dL) within the past 12 months * Active cancer * Severe daytime sleepiness (score \>15 at the Epworth Sleepiness Scale \[ESS\])81 * Current or recent (within the past 2 months) participation in other research studies at the discretion of study investigators * Inability to provide written consent and/or to speak and read English * Any other medical, geographic, or social factor making study participation impractical
Where it's running
-
Mayo Clinic in Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Naima Covassin, Ph.D. — Mayo Clinic
- Study coordinator: Perimenopause Study Team
- Email: PerimenopauseStdy@mayo.edu
- Phone: 507-255-8897
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Understanding immune clues to depression in perimenopause
This study tests whether immune and epigenetic changes during perimenopause help explain why some women develop depression.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.